Abcam PLC (LSE:ABC) - Overview

Stock Report

Abcam PLC ABC

Last Price
GBX819.50

Day Change
7.50|0.92%

As of 02/12/2016
17:11:48 GMT | GBX
Minimum 15 Minutes Delay.

Last Close812.00p
Day Range801.50 - 820.50
Mkt Cap1.67Bil
52-Wk Range572.00 - 905.50
Yield %1.01
ISINGB00B6774699
Volume485,845
P/E38.95
P/S9.60
P/CF34.84

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
Abcam PLC-5.65 
FTSE 100 TR GBP-1.21
 
Financials
201420152016
More ...
Income Statement
Turnover127.95144.03171.67
Operating Profit43.3145.7346.32
Net Profit34.0537.3837.43
Reported EPS17.0218.5718.53
Balance Sheet
Current Assets90.3199.84118.86
Non Current Assets115.67149.42209.91
Total Assets206.59249.95329.56
Current Liabilities16.8321.0633.29
Total Liabilities25.6935.8468.37
Total Equity180.90214.10261.19
Cash Flow
Operating Cash Flow51.2548.8956.80
Net Change in Cash21.401.5510.40
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
201757.4422.617.4636.254.869.251.13
201870.6228.5226.1728.731.1011.081.35

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
30/09/2016PurchaseLady Louise Patten of Wincanton836.0012,378103,480.00
30/09/2016PurchaseMr Murray Hennessy837.115,89549,348.00
30/09/2016Transfer inMr. Alan Hirzel0.0010,5380.00
26/09/2016Transfer OutDr. Jim Warwick0.0062,0000.00

Company Profile

Abcam PLC along with its subsidiaries is engaged in producing and distributing research-grade antibodies and associated protein research tools. It offers products including antibodies, biochemical, proteins, peptides, lysates, immunoassays & other kits.
 

Sector

Biotechnology

Market Position

194 of 1865 Companies

Index

FTSE AIM UK 50 ,FTSE AIM 100 ,FTSE AIM All Share

Outlook

(02/11/2016) "We remain confident that we can continue to build significant value for all of our stakeholders"

Next Event 07/03/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)32.6213.1416.27
Div Yld (E)1.224.184.36
PEG (E)2.070.360.00
ROCE49.76206.9680.66
Op Mrgn29.32-17.09-14.86
EPS Grwth15.749.6525.03
Dividends
PreviousLatest
More ...
Record Date18/03/1611/11/16
Ex-Div17/03/1610/11/16
Paid15/04/1602/12/16
Amnt2.356.56

Broker Sentiment

Strong Buy0
Buy2
Hold0
Sell1
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr Murray Hennessy
Chief Executive OfficerMr. Alan Hirzel
Chief Financial OfficerGavin Wood
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.